Breaking News
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
Aurobindo Pharma Limited Issues Voluntary Recall of Irbesartan Drug Substance due to the Detection of Trace Amounts of NDEA (NNitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)

Aurobindo Pharma Limited Issues Voluntary Recall of Irbesartan Drug Substance due to the Detection of Trace Amounts of NDEA (NNitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)

image_pdfDownload PDFimage_print

October 26, 2018

Audience: Consumer, Health Professional, Pharmacy

October 26, 2018 — Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartan due to the presence of an impurity, N-nitrosodiethylamine (NDEA). The impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC).

These 22 batches of Irbesartan drug substance were supplied to ScieGen Pharmaceuticals Inc., U.S. for the manufacturing of finished Irbesartan drug product (see attached annexure).

Aurobindo Pharma Limited has notified ScieGen Pharmaceuticals, Inc. of the recall and is arranging for the return of all available Irbesartan drug substance. Aurobindo Pharma Limited has further advised Sciegen Pharmaceuticals, Inc. to contact its distributors and retailers to return Irbesartan drug product and finished Irbesartan tablets that has been identified by Aurobindo Pharma Limited.

Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. Patients who are on Irbesartan should continue taking their medication, as the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using Irbesartan.

Adverse reactions or quality problems associated with the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

 Annexure -I
Irbesartan batches Supplied to US Customers

 

S.No Manufacturing Batch Number Dispatch Batch Number Date of Manufacture Date of Distribution Retest/Expiry Date Dispatch Qty Name and Location of the Customer NDEA Impurity Result ug/g
1 1601100782 1601101589 Jan-2016 Jan-2016 Dec-2016 90.29 Kg Sciegen Pharmaceuticals INC, USA 0.23
2 1601100783 1601101590 Jan-2016 3l-Jan-2016 Dec-2016 59.61 Kg Sciegen Pharmaceuticals INC, USA 0.28
3 1701111861 1701113404 l3-Sep-2017 7-0ct-2017 12-Sep-2020 88.48 Kg Sciegen Pharmaceuticals INC, USA 0.47
4 1701112170 1701113405 l8-Sep-2017 7-0ct-2017 l7-Sep-2020 90.92 Kg Sciegen Pharmaceuticals INC, USA 0.15
5 1701112501 1701113406 20-Sep-2017 7-0ct-2017 l9-Sep-2020 93.02 Kg Sciegen Pharmaceuticals INC, USA 1.61
6 1701112056 1701113407 l3-Sep-2017 7-0ct-2017 l2-Sep-2020 88.82 Kg Sciegen Pharmaceuticals INC, USA 0.53
7 1701112558 1701114283 2-0ct-2017 25-0ct-2017 l-Oct-2020 63.76 Kg Sciegen Pharmaceuticals INC, USA 0.6
8 1701112558 1701114284 2-0ct-2017 25-0ct-2017 l-Oct-2020 27.06 Kg Sciegen Pharmaceuticals INC, USA 0.6
9 1701I12559 1701114285 3-0ct-2017 25-0ct-2017 2-0ct-2020 91.82 Kg Sciegen Pharmaceuticals INC, USA 0.45
10 1701112589 1701114286 6-0ct-2017 25-0ct-2017 5-0ct-2020 90.32 Kg Sciegen Pharmaceuticals INC, USA 0.28
11 1701113300 1701114289 7-0ct-2017 25-0ct-2017 6-0ct-2020 91.32 Kg Sciegen Pharmaceuticals INC, USA 0.32
12 1701113301 1701114291 8-0ct-2017 25-0ct-2017 7-0ct-2020 90.12 Kg Sciegen Pharmaceuticals INC, USA 0.32
13 1701113302 1701114708 l7-0ct-2017 30-0ct-2017 l6-0ct-2020 80.82 Kg Sciegen Pharmaceuticals INC, USA 0.85
14 1701113312 1701114709 20-0ct-2017 30-0ct-2017 19 Oct 2020 86.82 Kg Sciegen Pharmaceuticals INC, USA 0.88
15 1701115460 1701117039 23-Nov-2017 2l-Dec-2017 22-Nov-2020 16.72 Kg Sciegen Pharmaceuticals INC, USA 0.31
16 1701115974 1701117040 29-Nov-2017 2l-Dec-2017 28-Nov-2020 91.12 Kg Sciegen Pharmaceuticals INC, USA 0.26
17 1701115460 1701117041 23-Nov-2017 2l-Dec-2017 22-Nov-2020 89.79 Kg Sciegen Pharmaceuticals INC, USA 0.31
18 1701115738 1701117042 24-Nov-2017 21-Dec-2017 23-Nov-2020 90.42 Kg Sciegen Pharmaceuticals INC, USA 0.38
19 1701115739 1701117043 25-Nov-2017 2l-Dec-2017 24-Nov-2020 89.79 Kg Sciegen Pharmaceuticals INC, USA 0.44
20 1701115740 1701117044 26-Nov-2017 2l-Dec-2017 25-Nov-2020 93.42 Kg Sciegen Pharmaceuticals INC, USA 0.34
21 1701115741 1701117045 27-Nov-2017 21-Dec-2017 26-Nov-2020 93.72 Kg Sciegen Pharmaceuticals INC, USA 0.39
22 1701115742 1701117046 28-Nov-2017 21-Dec-2017 27-Nov-2020 93.62 Kg Sciegen Pharmaceuticals INC, USA 0.31

Remark: For Dispatch batch no. 1701114283 & 1701114284, Mother Batch is common 170111255 8

For Dispatch batch no. 1701117039 & 1701117041, Mother Batch is common 1701115460

Total No. of Mother Batches: 20

Total No. of dispatch Batches: 22.

Source: FDA

Tagged with:

About author

Related Articles